董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Israel Shamay | 男 | Director | 55 | 12.80万 | 未持股 | 2020-03-27 |
| Abraham Sartani | 男 | Director | 73 | 未披露 | 未持股 | 2020-03-27 |
| Yaacov Goldman | 男 | Director | 64 | 未披露 | 未持股 | 2020-03-27 |
| Ilan Cohn | 男 | Chairman of the Board | 64 | 未披露 | 未持股 | 2020-03-27 |
| Pnina Fishman | 女 | Chief Executive Officer, Director | 71 | 208.60万 | 未持股 | 2020-03-27 |
| Guy Regev | 男 | Director | 50 | 12.00万 | 未持股 | 2020-03-27 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Sari Fishman | 女 | VP of Business Development | 48 | 未披露 | 未持股 | 2020-03-27 |
| Pnina Fishman | 女 | Chief Executive Officer, Director | 71 | 208.60万 | 未持股 | 2020-03-27 |
| Motti Farbstein | 男 | Chief Operating and Financial Officer | 56 | 123.90万 | 未持股 | 2020-03-27 |
董事简历
中英对照 | 中文 | 英文- Israel Shamay
-
Israel Shamay自2014年12月以来担任我们董事会的外部董事，是审计委员会和薪酬委员会（the Audit Committee和Compensation Committee）的成员。自2012年以来他担任MATIMOP以色列产业研发中心（MATIMOP Israeli Industry Center for R&D）（以色列首席科学家办公室的国际业务机构）战略举措的执行董事和美洲业务负责人，专注于发展和实施在美洲地区的工业研发和创新项目的合作平台。他从2006年到2012年担任MATIMOP欧洲合作的执行董事，在那里他负责架构设计、实现和评价在两国和欧洲的工业创新合作框架，使他们成为以色列行业与欧洲的的主要研发合作工具。在2010年和2011年之间他是the Israeli EUREKA Chairmanship Program的主管（EUREKA是欧洲最大的创新网络，拥有近40个成员国）。The Israeli EUREKA Chairmanship专注于为创新中小企业和扩大EUREKA的国际维度开发新的金融工具。从2002年开始他在一些国际研发项目中担任以色列的国家代表，从2005年开始担任欧盟研发框架项目（the EU Framework Programs for R&D）的专家评估者，从2006年到2009年管理以色列与the EU Global Satellite Navigation Program（欧盟全球卫星导航计划）——GALILEO的研发合作。从1991年至2001年他在全球范围内以色列高科技公司担任高级技术、营销和运营管理职位，包括RAD集团和Comverse Technologies。他是the Recanati School of Business at the Tel-Aviv University（特拉维夫大学Recanati商学院）的工商管理硕士毕业生，海法the Technion（理工学院）的毕业生，信息系统工程的教员。
Israel Shamay has served as external director since December 2014 and serves as a member on both the Audit Committee and Compensation Committee. Since 2012 Mr. Shamay has served as Executive Director, Strategic Initiatives and Head of the Americas Operations of MATIMOP Israeli Industry Center for R&D, the International Operations agency of the Israeli Office of the Israel Innovation Authority (formerly the Office of Chief Scientist), focusing on developing and implementing cooperation platforms for industrial R&D and innovation projects in the Americas region. From 2006 until 2012 Mr. Shamay served as Executive Director of European Cooperations at MATIMOP, where he was in charge of architecting, realizing and evaluating industrial innovation cooperation frameworks at bilateral and European level, making them a major R&D cooperation instrument for Israeli industry with Europe. Between 2010 and 2011 Mr. Shamay was Head of the Israeli EUREKA Chairmanship Program (EUREKA is Europe’s largest innovation network with nearly 40 member states). The Israeli EUREKA Chairmanship focused on developing new financial instruments for innovative small and medium sized enterprises and on expanding EUREKA’s international dimension. From 2002 Mr. Shamay served as Israel’s National Representative in several international R&D programs, from 2005 as an expert evaluator for the EU Framework Programs for R&D and from 2006 until 2009 managed the Israeli R&D collaboration with the EU Global Satellite Navigation Program - GALILEO. From 1991 until 2001 Mr. Shamay served in senior technical, marketing and executive positions in Israeli hi-tech companies operating globally, including the RAD group and Comverse Technologies. Mr. Shamay is an MBA graduate of the Recanati School of Business at the Tel-Aviv University and a graduate of the Technion in Haifa, faculty of Information Systems Engineering. - Israel Shamay自2014年12月以来担任我们董事会的外部董事，是审计委员会和薪酬委员会（the Audit Committee和Compensation Committee）的成员。自2012年以来他担任MATIMOP以色列产业研发中心（MATIMOP Israeli Industry Center for R&D）（以色列首席科学家办公室的国际业务机构）战略举措的执行董事和美洲业务负责人，专注于发展和实施在美洲地区的工业研发和创新项目的合作平台。他从2006年到2012年担任MATIMOP欧洲合作的执行董事，在那里他负责架构设计、实现和评价在两国和欧洲的工业创新合作框架，使他们成为以色列行业与欧洲的的主要研发合作工具。在2010年和2011年之间他是the Israeli EUREKA Chairmanship Program的主管（EUREKA是欧洲最大的创新网络，拥有近40个成员国）。The Israeli EUREKA Chairmanship专注于为创新中小企业和扩大EUREKA的国际维度开发新的金融工具。从2002年开始他在一些国际研发项目中担任以色列的国家代表，从2005年开始担任欧盟研发框架项目（the EU Framework Programs for R&D）的专家评估者，从2006年到2009年管理以色列与the EU Global Satellite Navigation Program（欧盟全球卫星导航计划）——GALILEO的研发合作。从1991年至2001年他在全球范围内以色列高科技公司担任高级技术、营销和运营管理职位，包括RAD集团和Comverse Technologies。他是the Recanati School of Business at the Tel-Aviv University（特拉维夫大学Recanati商学院）的工商管理硕士毕业生，海法the Technion（理工学院）的毕业生，信息系统工程的教员。
- Israel Shamay has served as external director since December 2014 and serves as a member on both the Audit Committee and Compensation Committee. Since 2012 Mr. Shamay has served as Executive Director, Strategic Initiatives and Head of the Americas Operations of MATIMOP Israeli Industry Center for R&D, the International Operations agency of the Israeli Office of the Israel Innovation Authority (formerly the Office of Chief Scientist), focusing on developing and implementing cooperation platforms for industrial R&D and innovation projects in the Americas region. From 2006 until 2012 Mr. Shamay served as Executive Director of European Cooperations at MATIMOP, where he was in charge of architecting, realizing and evaluating industrial innovation cooperation frameworks at bilateral and European level, making them a major R&D cooperation instrument for Israeli industry with Europe. Between 2010 and 2011 Mr. Shamay was Head of the Israeli EUREKA Chairmanship Program (EUREKA is Europe’s largest innovation network with nearly 40 member states). The Israeli EUREKA Chairmanship focused on developing new financial instruments for innovative small and medium sized enterprises and on expanding EUREKA’s international dimension. From 2002 Mr. Shamay served as Israel’s National Representative in several international R&D programs, from 2005 as an expert evaluator for the EU Framework Programs for R&D and from 2006 until 2009 managed the Israeli R&D collaboration with the EU Global Satellite Navigation Program - GALILEO. From 1991 until 2001 Mr. Shamay served in senior technical, marketing and executive positions in Israeli hi-tech companies operating globally, including the RAD group and Comverse Technologies. Mr. Shamay is an MBA graduate of the Recanati School of Business at the Tel-Aviv University and a graduate of the Technion in Haifa, faculty of Information Systems Engineering.
- Abraham Sartani
-
Abraham Sartani，2001年以来，他一直任职我们的董事会。他在制药行业拥有30年以上的经验，目前担任制药和医疗设备公司的顾问。他是多家科学管理协会的成员，也是泌尿外科、疼痛治疗和高血压领域的大量出版物和专利的作者或合著者。他目前也任职于Akkadeas Pharma Srl公司的董事会，是联席创始合伙人。从1985年到2008年，他曾担任Recordati公司（欧洲专业制药公司）的研发和许可副总裁。加入Recordati公司之前，他曾任职Farmitalia-Carlo Erba公司，担任多种职务，包括欧洲医疗董事（从1980年到1985年）。
Abraham Sartani has served on our Board of Directors since 2001. Dr. Sartani has over 30 years of experience in the pharmaceuticals industry and currently acts as a consultant to pharmaceutical and medical device companies. Dr. Sartani is a member of a number of scientific and management societies and the author or co-author of numerous publications and patents in the urology, pain treatment and hypertension fields. Dr. Sartani previously served on the Board of Directors of Akkadeas Pharma Srl formerly Arkadia Pharma and was a co-founder. From 1985 until 2008 Dr. Sartani was the Vice-President of R&D and Licensing and Group coordinator of B&D of Recordati, a European specialty pharmaceutical company. Prior to joining Recordati, from 1980 until 1985 Dr. Sartani was employed at Farmitalia-Carlo Erba, serving in a number of capacities, including as the Medical Director for Europe. - Abraham Sartani，2001年以来，他一直任职我们的董事会。他在制药行业拥有30年以上的经验，目前担任制药和医疗设备公司的顾问。他是多家科学管理协会的成员，也是泌尿外科、疼痛治疗和高血压领域的大量出版物和专利的作者或合著者。他目前也任职于Akkadeas Pharma Srl公司的董事会，是联席创始合伙人。从1985年到2008年，他曾担任Recordati公司（欧洲专业制药公司）的研发和许可副总裁。加入Recordati公司之前，他曾任职Farmitalia-Carlo Erba公司，担任多种职务，包括欧洲医疗董事（从1980年到1985年）。
- Abraham Sartani has served on our Board of Directors since 2001. Dr. Sartani has over 30 years of experience in the pharmaceuticals industry and currently acts as a consultant to pharmaceutical and medical device companies. Dr. Sartani is a member of a number of scientific and management societies and the author or co-author of numerous publications and patents in the urology, pain treatment and hypertension fields. Dr. Sartani previously served on the Board of Directors of Akkadeas Pharma Srl formerly Arkadia Pharma and was a co-founder. From 1985 until 2008 Dr. Sartani was the Vice-President of R&D and Licensing and Group coordinator of B&D of Recordati, a European specialty pharmaceutical company. Prior to joining Recordati, from 1980 until 1985 Dr. Sartani was employed at Farmitalia-Carlo Erba, serving in a number of capacities, including as the Medical Director for Europe.
- Yaacov Goldman
-
Yaacov Goldman自2017年8月起担任外部董事。Goldman先生通过其全资公司Maanit Goldman Management&Investments-2002 Ltd.为战略金融领域的公司提供咨询服务。Goldman先生还担任Avgol Industries 1953 Ltd.，Mivne Real Estate K.D Ltd.，Fattal Properties（欧洲）的董事Goldman先生于2004年10月至2008年9月担任以色列注册会计师协会同行评审协会的专业秘书。从1981年开始，Goldman先生在凯塞尔曼和凯塞尔曼（普华永道的以色列成员公司）工作了19年，从1991年到2000年，他是普华永道的以色列成员公司的合伙人，然后是高级合伙人。从2000年9月到2001年11月，Goldman先生担任Argoquest Holdings，LLC的常务董事。Goldman先生拥有特拉维夫大学经济学和会计学士学位，是一名注册会计师（以色列）。
Yaacov Goldman has been nominated to serve as a director effective upon completion of the offering. He provides consulting services to companies in strategic-financial areas, through his wholly owned company, Maanit-Goldman Management & Investments -2002 Ltd. Mr. Goldman has served as external director for Can-Fite BioPharma Ltd. NYSE:CANF since August 2017. Mr. Goldman also serves as a director of Avgol Industries 1953 Ltd., Mivne Real Estate (K.D) Ltd., Fattal Properties (Europe) Ltd. and Prashkovsky Investments and Construction Ltd. Mr. Goldman served as the Professional Secretary of the Peer Review Institute of the Certified Public Accountants Institute in Israel from October 2004 until September 2008. Commencing in 1981 Mr. Goldman worked for Kesselman & Kesselman (Israeli member firm of PricewaterhouseCoopers) for 19 years, and from 1991 until 2000 as a partner and then senior partner of such firm. From September 2000 until November 2001 Mr. Goldman served as managing director of Argoquest Holdings, LLC. Mr. Goldman holds a B.A. degree in Economics and Accounting from Tel Aviv University and is a Certified Public Accountant (Israel). - Yaacov Goldman自2017年8月起担任外部董事。Goldman先生通过其全资公司Maanit Goldman Management&Investments-2002 Ltd.为战略金融领域的公司提供咨询服务。Goldman先生还担任Avgol Industries 1953 Ltd.，Mivne Real Estate K.D Ltd.，Fattal Properties（欧洲）的董事Goldman先生于2004年10月至2008年9月担任以色列注册会计师协会同行评审协会的专业秘书。从1981年开始，Goldman先生在凯塞尔曼和凯塞尔曼（普华永道的以色列成员公司）工作了19年，从1991年到2000年，他是普华永道的以色列成员公司的合伙人，然后是高级合伙人。从2000年9月到2001年11月，Goldman先生担任Argoquest Holdings，LLC的常务董事。Goldman先生拥有特拉维夫大学经济学和会计学士学位，是一名注册会计师（以色列）。
- Yaacov Goldman has been nominated to serve as a director effective upon completion of the offering. He provides consulting services to companies in strategic-financial areas, through his wholly owned company, Maanit-Goldman Management & Investments -2002 Ltd. Mr. Goldman has served as external director for Can-Fite BioPharma Ltd. NYSE:CANF since August 2017. Mr. Goldman also serves as a director of Avgol Industries 1953 Ltd., Mivne Real Estate (K.D) Ltd., Fattal Properties (Europe) Ltd. and Prashkovsky Investments and Construction Ltd. Mr. Goldman served as the Professional Secretary of the Peer Review Institute of the Certified Public Accountants Institute in Israel from October 2004 until September 2008. Commencing in 1981 Mr. Goldman worked for Kesselman & Kesselman (Israeli member firm of PricewaterhouseCoopers) for 19 years, and from 1991 until 2000 as a partner and then senior partner of such firm. From September 2000 until November 2001 Mr. Goldman served as managing director of Argoquest Holdings, LLC. Mr. Goldman holds a B.A. degree in Economics and Accounting from Tel Aviv University and is a Certified Public Accountant (Israel).
- Ilan Cohn
-
Ilan Cohn博士自1986年起在专利律师事务所Reinhold Cohn and Partners担任一名律师，现在是该律师事务所的一名专利律师和高级合伙人。Cohn博士是Can-Fite的联合创始人，在2004年9月之前一直担任该公司的首席执行官；自1994年起担任该公司的一名董事；自2013年5月30日起一直担任该公司董事会的主席。2011年11月21日起，Cohn博士一直担任OphthaliX的一名董事。Cohn博士拥有生物学博士学位，并且在生物制药领域担任律师有许多年的经历。他现在还在一些生命科学公司的董事会任职，其中包括Discovery Laboratories Inc.（前Ansan Pharmaceuticals，一家美国上市公司）；Cohn博士还参与生命科学行业的风险资本紫荆管理。Cohn博士曾在美国-以色列科学和科技委员会的生物技术委员会担任联合主席多年。Cohn先生目前还是I.C.R.C Management Ltd, Famillion BVI Ltd. 以及 Famillion Ltd.（Famillion BVI Ltd.子公司）的一名董事。Cohn先生拥有耶路撒冷希伯来大学的生物学博士学位。
Ilan Cohn is a patent attorney and senior partner at the patent attorney firm Reinhold Cohn and Partners, where he has been an attorney since 1986. Dr. Cohn co-founded Can-Fite, served as its Chief Executive Officer until September 2004 served on our Board of Directors since 1994 and since May 30 2013 serves as the Chairman of the Can-Fite Board of Directors. Dr. Cohn has also been a director of OphthaliX since November 21 2011. Dr. Cohn holds a Ph.D. in biology and is a patent attorney with many years of experience in the biopharmaceutical field. He has served on the Board of Directors of a number of life science companies, including Discovery Laboratories Inc. formerly Ansan Pharmaceuticals, a U.S. public company. Dr. Cohn has also been involved in the past in management of venture capital funds focused on investments in the life sciences industry. Dr. Cohn served a number of years as a co-chairman of the Biotech Committee of the US-Israeli Science and Technology Commission. Dr. Cohn is also currently a member of the Board of Directors of I.C.R.C. Management Ltd, Famillion BVI Ltd. and Famillion Ltd. (a subsidiary of Famillion BVI Ltd.). Dr. Cohn holds a Ph.D. in Biology from the Hebrew University of Jerusalem. - Ilan Cohn博士自1986年起在专利律师事务所Reinhold Cohn and Partners担任一名律师，现在是该律师事务所的一名专利律师和高级合伙人。Cohn博士是Can-Fite的联合创始人，在2004年9月之前一直担任该公司的首席执行官；自1994年起担任该公司的一名董事；自2013年5月30日起一直担任该公司董事会的主席。2011年11月21日起，Cohn博士一直担任OphthaliX的一名董事。Cohn博士拥有生物学博士学位，并且在生物制药领域担任律师有许多年的经历。他现在还在一些生命科学公司的董事会任职，其中包括Discovery Laboratories Inc.（前Ansan Pharmaceuticals，一家美国上市公司）；Cohn博士还参与生命科学行业的风险资本紫荆管理。Cohn博士曾在美国-以色列科学和科技委员会的生物技术委员会担任联合主席多年。Cohn先生目前还是I.C.R.C Management Ltd, Famillion BVI Ltd. 以及 Famillion Ltd.（Famillion BVI Ltd.子公司）的一名董事。Cohn先生拥有耶路撒冷希伯来大学的生物学博士学位。
- Ilan Cohn is a patent attorney and senior partner at the patent attorney firm Reinhold Cohn and Partners, where he has been an attorney since 1986. Dr. Cohn co-founded Can-Fite, served as its Chief Executive Officer until September 2004 served on our Board of Directors since 1994 and since May 30 2013 serves as the Chairman of the Can-Fite Board of Directors. Dr. Cohn has also been a director of OphthaliX since November 21 2011. Dr. Cohn holds a Ph.D. in biology and is a patent attorney with many years of experience in the biopharmaceutical field. He has served on the Board of Directors of a number of life science companies, including Discovery Laboratories Inc. formerly Ansan Pharmaceuticals, a U.S. public company. Dr. Cohn has also been involved in the past in management of venture capital funds focused on investments in the life sciences industry. Dr. Cohn served a number of years as a co-chairman of the Biotech Committee of the US-Israeli Science and Technology Commission. Dr. Cohn is also currently a member of the Board of Directors of I.C.R.C. Management Ltd, Famillion BVI Ltd. and Famillion Ltd. (a subsidiary of Famillion BVI Ltd.). Dr. Cohn holds a Ph.D. in Biology from the Hebrew University of Jerusalem.
- Pnina Fishman
-
Pnina Fishman博士是Can-Fite的联合创始人，并自2005年起一直在我们公司的董事会任职。2011年11月21日到2012年12月31日期间，她曾担任OphthaliX 的首席执行官。Fishman博士是Can-Fite的科学奠基人，曾是 Life Sciences的专家，并主管着以色列Felsenstein Medical Research 机构和 Rabin Medical Center的 临床和肿瘤免疫学实验室。Fishman博士是超过150本出版刊物的作家或联合作者，并在许多主要科学会议上呈现了她的研究发现。她过去的管理经历包括在Mor Research Application（以色列最大的医疗供应商）担任7年的首席执行官。Mor Research Application还曾是以色列第一家医疗研究组织。Fishman博士目前还是F.D Consulting Ltd., Ultratrend Ltd., EyeFite Ltd. 和 OphthaliX Inc.董事会成员。Fishman博士拥有Bar Ilan University 的免疫学博士学位。
Pnina Fishman co-founded Can-Fite and has served as our Chief Executive Officer and served on our Board of Directors since September 2005. Dr. Fishman is the scientific founder of Can-Fite and was previously a professor of Life Sciences and headed the Laboratory of Clinical and Tumor Immunology at the Felsenstein Medical Research Institute, Rabin Medical Center, Israel. Dr. Fishman has authored or co-authored over 150 publications and presented the findings of her research at many major scientific meetings. Her past managerial experience included seven years as Chief Executive Officer of Mor Research Application, the technology transfer arm of Clalit Health Services, the largest healthcare provider in Israel. Mor Research Application was also the first clinical research organization in Israel. Dr. Fishman currently also serves as a member of the Board of Directors of F.D Consulting Ltd., Ultratrend Ltd., and Eye-Fite Ltd. Dr. Fishman holds a Ph.D. in Immunology from the Bar Ilan University in Ramat Gan, Israel. - Pnina Fishman博士是Can-Fite的联合创始人，并自2005年起一直在我们公司的董事会任职。2011年11月21日到2012年12月31日期间，她曾担任OphthaliX 的首席执行官。Fishman博士是Can-Fite的科学奠基人，曾是 Life Sciences的专家，并主管着以色列Felsenstein Medical Research 机构和 Rabin Medical Center的 临床和肿瘤免疫学实验室。Fishman博士是超过150本出版刊物的作家或联合作者，并在许多主要科学会议上呈现了她的研究发现。她过去的管理经历包括在Mor Research Application（以色列最大的医疗供应商）担任7年的首席执行官。Mor Research Application还曾是以色列第一家医疗研究组织。Fishman博士目前还是F.D Consulting Ltd., Ultratrend Ltd., EyeFite Ltd. 和 OphthaliX Inc.董事会成员。Fishman博士拥有Bar Ilan University 的免疫学博士学位。
- Pnina Fishman co-founded Can-Fite and has served as our Chief Executive Officer and served on our Board of Directors since September 2005. Dr. Fishman is the scientific founder of Can-Fite and was previously a professor of Life Sciences and headed the Laboratory of Clinical and Tumor Immunology at the Felsenstein Medical Research Institute, Rabin Medical Center, Israel. Dr. Fishman has authored or co-authored over 150 publications and presented the findings of her research at many major scientific meetings. Her past managerial experience included seven years as Chief Executive Officer of Mor Research Application, the technology transfer arm of Clalit Health Services, the largest healthcare provider in Israel. Mor Research Application was also the first clinical research organization in Israel. Dr. Fishman currently also serves as a member of the Board of Directors of F.D Consulting Ltd., Ultratrend Ltd., and Eye-Fite Ltd. Dr. Fishman holds a Ph.D. in Immunology from the Bar Ilan University in Ramat Gan, Israel.
- Guy Regev
-
Guy Regev在商业企业的会计，财务管理，主管部门和管理部门有超过12年的任职经历。他自2011年7月起一直在我们公司的董事会任职，并自2014年2月起，一直是我们公司审计委员会和薪酬委员会的成员。自2011年11月起，Regev先生还一直是OphthaliX的一名董事。Regev先生目前是Gaon Holdings Ltd.（一家以色列上市贸易公司，主要在自来水清洁，财务服务和零售贸易三个方面运营）的首席执行官。Regev先生目前还是Middle East Tube Company Ltd（一家以色列上市贸易公司，从事钢管制造和电镀服务）的首席执行官。另外，Regev先生还是Shaked Global Group Ltd（一家为环保关联和科技公司提供资本增值服务的私营股权公司，或称为Shaked公司）的首席执行官。2008年初，Regev先生加入了Shaked并在2014年4月离职。2011年11月以来，Regev先生还一直是OphthaliX公司的一名董事。在加入Shaked之前，2001年到2008年期间，Regev先生曾是HCH（以色列最大的基础设施公司）商业业务部的副主管。他在HCH公司的负责各个业务单元的巩固和财务复苏。在此之前，Regev先生曾在Blue-Green Ltd.（HCH的环境服务子公司）担任许多角色，包括首席财务官和之后的首席执行官。1999年到2001年期间，Regev先生曾是以色列Deloitte & Touche公司的经理。Regev先生拥有Law Israel的法学学士学位，是一位有证律师以及自1999年起成为一名注册会计师。Regev先生现在还是The Green Way Ltd, Shtang Construction 和Engineering Ltd, R.I.B.E. Consulting & Investment Ltd., Shaked Group Ltd, Aqua Investments Ltd, Middle East Tube Company Ltd, Middle East Tube - Industries 2001 Ltd, Middle East Tubes - Galvanizing -1994 Ltd, I-Solar Greentech Ltd, Plassim Infrastructure Ltd, Plassim Advanced Solutions in Sanitation Ltd, Hakohav Valves Industries Metal -1987 Ltd, Aqua Flowing Infrastructure Control Systems Ltd, Metzerplas Agriculture Cooperative Ltd, B. Gaon Retail & Trading Ltd, Gaon Agro - Rimon Management Services Ltd, B. Gaon Business -2004 Ltd, Gaon Antan Investments Ltd, Or Asaf Investments Ltd, Hamashbir Holdings -1999 Ltd, G.A.L Water Technologies Ltd, I.M.G. Retail Israel Ltd 以及 AHAVA Holdings LTD.这么多家公司的一名董事。
Guy Regev has over twelve years of experience in accounting, financial management and control and general management of commercial enterprises. He has served on our Board of Directors since July 2011 and has served as a member of our Audit Committee and Compensation Committee since February 2014. Mr. Regev has also been a director of OphthaliX since November 2011. Mr. Regev is currently the Chief Executive Officer of Gaon Holdings Ltd, a publicly traded Israeli holding company traded on the TASE which focuses on three areas of operation - Cleantech / Water, Financial Services, Retail/Trading. Mr. Regev is currently also the Chief Executive Officer of Middle East Tube Company Ltd a publicly traded Israeli company traded on the TASE which focuses on steel pipe manufacturing and galvanization services. Mr. Regev was the Chief Executive Officer of Shaked Global Group Ltd, a privately-held equity investment firm that provides value added capital to environmental-related companies and technologies. Prior to joining Shaked, from 2001 to 2008 Mr. Regev was Vice President of Commercial Business at Housing & Construction Holding, or HCH, Israel’s largest infrastructure company. His duties included being responsible for the consolidation and financial recovery of various business units within HCH. Prior to that, Mr. Regev carried several roles within the group including as a Chief Financial Officer and later the Chief Executive Officer of Blue-Green Ltd., the environmental services subsidiary of HCH. Between 1999 and 2001 Mr. Regev was a manager at Deloitte & Touche, Israel. Mr. Regev holds an LLB degree in Law Israel and is a licensed attorney and has been a licensed CPA since 1999. Mr. Regev is also a director of, The Green Way Ltd, Shtang Construction and Engineering Ltd, R.I.B.E. Consulting & Investment Ltd., Middle East Tube Company Ltd, Middle East Tube - Industries 2001 Ltd, Middle East Tubes - Galvanizing -1994 Ltd, I-Solar Greentech Ltd, Plassim Infrastructure Ltd, Plassim Advanced Solutions in Sanitation Ltd, Hakohav Valves Industries Metal -1987 Ltd, Metzerplas Agriculture Cooperative Ltd, B. Gaon Retail & Trading Ltd, Gaon Agro - Rimon Management Services Ltd, B. Gaon Business -2004 Ltd, Gaon Antan Investments Ltd, Or Asaf Investments Ltd, Hamashbir Holdings -1999 Ltd, and AHAVA Holdings LTD. - Guy Regev在商业企业的会计，财务管理，主管部门和管理部门有超过12年的任职经历。他自2011年7月起一直在我们公司的董事会任职，并自2014年2月起，一直是我们公司审计委员会和薪酬委员会的成员。自2011年11月起，Regev先生还一直是OphthaliX的一名董事。Regev先生目前是Gaon Holdings Ltd.（一家以色列上市贸易公司，主要在自来水清洁，财务服务和零售贸易三个方面运营）的首席执行官。Regev先生目前还是Middle East Tube Company Ltd（一家以色列上市贸易公司，从事钢管制造和电镀服务）的首席执行官。另外，Regev先生还是Shaked Global Group Ltd（一家为环保关联和科技公司提供资本增值服务的私营股权公司，或称为Shaked公司）的首席执行官。2008年初，Regev先生加入了Shaked并在2014年4月离职。2011年11月以来，Regev先生还一直是OphthaliX公司的一名董事。在加入Shaked之前，2001年到2008年期间，Regev先生曾是HCH（以色列最大的基础设施公司）商业业务部的副主管。他在HCH公司的负责各个业务单元的巩固和财务复苏。在此之前，Regev先生曾在Blue-Green Ltd.（HCH的环境服务子公司）担任许多角色，包括首席财务官和之后的首席执行官。1999年到2001年期间，Regev先生曾是以色列Deloitte & Touche公司的经理。Regev先生拥有Law Israel的法学学士学位，是一位有证律师以及自1999年起成为一名注册会计师。Regev先生现在还是The Green Way Ltd, Shtang Construction 和Engineering Ltd, R.I.B.E. Consulting & Investment Ltd., Shaked Group Ltd, Aqua Investments Ltd, Middle East Tube Company Ltd, Middle East Tube - Industries 2001 Ltd, Middle East Tubes - Galvanizing -1994 Ltd, I-Solar Greentech Ltd, Plassim Infrastructure Ltd, Plassim Advanced Solutions in Sanitation Ltd, Hakohav Valves Industries Metal -1987 Ltd, Aqua Flowing Infrastructure Control Systems Ltd, Metzerplas Agriculture Cooperative Ltd, B. Gaon Retail & Trading Ltd, Gaon Agro - Rimon Management Services Ltd, B. Gaon Business -2004 Ltd, Gaon Antan Investments Ltd, Or Asaf Investments Ltd, Hamashbir Holdings -1999 Ltd, G.A.L Water Technologies Ltd, I.M.G. Retail Israel Ltd 以及 AHAVA Holdings LTD.这么多家公司的一名董事。
- Guy Regev has over twelve years of experience in accounting, financial management and control and general management of commercial enterprises. He has served on our Board of Directors since July 2011 and has served as a member of our Audit Committee and Compensation Committee since February 2014. Mr. Regev has also been a director of OphthaliX since November 2011. Mr. Regev is currently the Chief Executive Officer of Gaon Holdings Ltd, a publicly traded Israeli holding company traded on the TASE which focuses on three areas of operation - Cleantech / Water, Financial Services, Retail/Trading. Mr. Regev is currently also the Chief Executive Officer of Middle East Tube Company Ltd a publicly traded Israeli company traded on the TASE which focuses on steel pipe manufacturing and galvanization services. Mr. Regev was the Chief Executive Officer of Shaked Global Group Ltd, a privately-held equity investment firm that provides value added capital to environmental-related companies and technologies. Prior to joining Shaked, from 2001 to 2008 Mr. Regev was Vice President of Commercial Business at Housing & Construction Holding, or HCH, Israel’s largest infrastructure company. His duties included being responsible for the consolidation and financial recovery of various business units within HCH. Prior to that, Mr. Regev carried several roles within the group including as a Chief Financial Officer and later the Chief Executive Officer of Blue-Green Ltd., the environmental services subsidiary of HCH. Between 1999 and 2001 Mr. Regev was a manager at Deloitte & Touche, Israel. Mr. Regev holds an LLB degree in Law Israel and is a licensed attorney and has been a licensed CPA since 1999. Mr. Regev is also a director of, The Green Way Ltd, Shtang Construction and Engineering Ltd, R.I.B.E. Consulting & Investment Ltd., Middle East Tube Company Ltd, Middle East Tube - Industries 2001 Ltd, Middle East Tubes - Galvanizing -1994 Ltd, I-Solar Greentech Ltd, Plassim Infrastructure Ltd, Plassim Advanced Solutions in Sanitation Ltd, Hakohav Valves Industries Metal -1987 Ltd, Metzerplas Agriculture Cooperative Ltd, B. Gaon Retail & Trading Ltd, Gaon Agro - Rimon Management Services Ltd, B. Gaon Business -2004 Ltd, Gaon Antan Investments Ltd, Or Asaf Investments Ltd, Hamashbir Holdings -1999 Ltd, and AHAVA Holdings LTD.
高管简历
中英对照 | 中文 | 英文- Sari Fishman
Sari Fishman曾担任我们的临床事务总监（从2004年到2014年）、业务发展总监（从2014年到2017年），并自2017年起担任业务发展副总裁。Fishman博士在以色列拉马特甘的巴伊兰大学（Bar-Ilan University）获得博士学位。
Sari Fishman has served as our Director Clinical Affairs from 2004 to 2014 Director of Business Development from 2014 to 2017 and since 2017 serves as VP of Business Development. Dr. Fishman gained her Ph.D. at the Bar-Ilan University, Ramat-Gan, Israel.- Sari Fishman曾担任我们的临床事务总监（从2004年到2014年）、业务发展总监（从2014年到2017年），并自2017年起担任业务发展副总裁。Fishman博士在以色列拉马特甘的巴伊兰大学（Bar-Ilan University）获得博士学位。
- Sari Fishman has served as our Director Clinical Affairs from 2004 to 2014 Director of Business Development from 2014 to 2017 and since 2017 serves as VP of Business Development. Dr. Fishman gained her Ph.D. at the Bar-Ilan University, Ramat-Gan, Israel.
- Pnina Fishman
Pnina Fishman博士是Can-Fite的联合创始人，并自2005年起一直在我们公司的董事会任职。2011年11月21日到2012年12月31日期间，她曾担任OphthaliX 的首席执行官。Fishman博士是Can-Fite的科学奠基人，曾是 Life Sciences的专家，并主管着以色列Felsenstein Medical Research 机构和 Rabin Medical Center的 临床和肿瘤免疫学实验室。Fishman博士是超过150本出版刊物的作家或联合作者，并在许多主要科学会议上呈现了她的研究发现。她过去的管理经历包括在Mor Research Application（以色列最大的医疗供应商）担任7年的首席执行官。Mor Research Application还曾是以色列第一家医疗研究组织。Fishman博士目前还是F.D Consulting Ltd., Ultratrend Ltd., EyeFite Ltd. 和 OphthaliX Inc.董事会成员。Fishman博士拥有Bar Ilan University 的免疫学博士学位。
Pnina Fishman co-founded Can-Fite and has served as our Chief Executive Officer and served on our Board of Directors since September 2005. Dr. Fishman is the scientific founder of Can-Fite and was previously a professor of Life Sciences and headed the Laboratory of Clinical and Tumor Immunology at the Felsenstein Medical Research Institute, Rabin Medical Center, Israel. Dr. Fishman has authored or co-authored over 150 publications and presented the findings of her research at many major scientific meetings. Her past managerial experience included seven years as Chief Executive Officer of Mor Research Application, the technology transfer arm of Clalit Health Services, the largest healthcare provider in Israel. Mor Research Application was also the first clinical research organization in Israel. Dr. Fishman currently also serves as a member of the Board of Directors of F.D Consulting Ltd., Ultratrend Ltd., and Eye-Fite Ltd. Dr. Fishman holds a Ph.D. in Immunology from the Bar Ilan University in Ramat Gan, Israel.- Pnina Fishman博士是Can-Fite的联合创始人，并自2005年起一直在我们公司的董事会任职。2011年11月21日到2012年12月31日期间，她曾担任OphthaliX 的首席执行官。Fishman博士是Can-Fite的科学奠基人，曾是 Life Sciences的专家，并主管着以色列Felsenstein Medical Research 机构和 Rabin Medical Center的 临床和肿瘤免疫学实验室。Fishman博士是超过150本出版刊物的作家或联合作者，并在许多主要科学会议上呈现了她的研究发现。她过去的管理经历包括在Mor Research Application（以色列最大的医疗供应商）担任7年的首席执行官。Mor Research Application还曾是以色列第一家医疗研究组织。Fishman博士目前还是F.D Consulting Ltd., Ultratrend Ltd., EyeFite Ltd. 和 OphthaliX Inc.董事会成员。Fishman博士拥有Bar Ilan University 的免疫学博士学位。
- Pnina Fishman co-founded Can-Fite and has served as our Chief Executive Officer and served on our Board of Directors since September 2005. Dr. Fishman is the scientific founder of Can-Fite and was previously a professor of Life Sciences and headed the Laboratory of Clinical and Tumor Immunology at the Felsenstein Medical Research Institute, Rabin Medical Center, Israel. Dr. Fishman has authored or co-authored over 150 publications and presented the findings of her research at many major scientific meetings. Her past managerial experience included seven years as Chief Executive Officer of Mor Research Application, the technology transfer arm of Clalit Health Services, the largest healthcare provider in Israel. Mor Research Application was also the first clinical research organization in Israel. Dr. Fishman currently also serves as a member of the Board of Directors of F.D Consulting Ltd., Ultratrend Ltd., and Eye-Fite Ltd. Dr. Fishman holds a Ph.D. in Immunology from the Bar Ilan University in Ramat Gan, Israel.
- Motti Farbstein
Motti Farbstein自2003年以来一直在Can-Fite工作。Farbstein先生自2003年8月到2005年5月起曾担任我们公司的首席运营官，并在那之后曾担任首席运营官还财务官。Farbstein先生在2011年7月起担任EyeFite Ltd.的董事。Farbstein先生过去的管理经历包括在Mor Research Application，即一家Clalit Health Services（以色列最大的医疗供应商）的附属机构下 所有医院和研究中心知识产权的商品化管理的公司担任7年的副总裁。
Motti Farbstein has been with Can-Fite since 2003. Mr. Farbstein served as our Chief Operating Officer from August 2003 until May 2005 and from that date onwards he served as Chief Operating and Financial Officer. Mr. Farbstein also serves as a director of Eye-Fite Ltd. since July 2011. Mr. Farbstein’s past managerial experience includes seven years as Vice President of Mor Research Application, a company that managed the commercialization of the intellectual property of all hospitals and research centers affiliated with Clalit Health Services, which is the largest healthcare provider in Israel and was Israel’s first clinical CRO. Mr. Farbstein also has extensive experience in the data management of clinical trials.- Motti Farbstein自2003年以来一直在Can-Fite工作。Farbstein先生自2003年8月到2005年5月起曾担任我们公司的首席运营官，并在那之后曾担任首席运营官还财务官。Farbstein先生在2011年7月起担任EyeFite Ltd.的董事。Farbstein先生过去的管理经历包括在Mor Research Application，即一家Clalit Health Services（以色列最大的医疗供应商）的附属机构下 所有医院和研究中心知识产权的商品化管理的公司担任7年的副总裁。
- Motti Farbstein has been with Can-Fite since 2003. Mr. Farbstein served as our Chief Operating Officer from August 2003 until May 2005 and from that date onwards he served as Chief Operating and Financial Officer. Mr. Farbstein also serves as a director of Eye-Fite Ltd. since July 2011. Mr. Farbstein’s past managerial experience includes seven years as Vice President of Mor Research Application, a company that managed the commercialization of the intellectual property of all hospitals and research centers affiliated with Clalit Health Services, which is the largest healthcare provider in Israel and was Israel’s first clinical CRO. Mr. Farbstein also has extensive experience in the data management of clinical trials.